Aastrom Biosciences 2007 2nd-Quarter Results

[7 February 2007] Ann Arbor, MI-based Aastrom Biosciences Inc./span> reported 2007 2nd-quarter results. For the three months ended 31 December 2006, Aastrom had revenues of $158,000.

   revenue:  $158,000 
   total costs and expenses: $4,898,000 
   research and development expenses:  $2,563,000 
   net loss: $4,225,000, or $.04 per share
   cash: $36,300,000

For the six months ended 31 December 2006, Aastrom's net loss was $8,282,000 or $0.07 per share.

Finance.Yahoo.com:: ASTM

  1. Aastrom's net loss for the 2007 1st quarter was $_________________.

  2. No or Yes: More than half of Aastrom's 2007 2nd-quarter net loss was due to research and development expenses.

  3. Based upon Aastrom's 2007 2nd-quarter loss per share, there are approximately ___________________ outstanding ASTM shares.

More... Aastrom Biosciences Inc. in a Nutshell

The following was copied from Aastrom.com.

   "Aastrom is developing autologous stem cell products for 
    use in regenerative medicine. Aastrom's platform manufacturing 
    technology enables the production of patient-specific cell 
    products with multiple tissue regenerative capabilities from 
    a small sample of the patient's bone marrow."

Creator: Gerald D. Thurman [gthurman@gmail.com]
Created: 07 February 2007

Creative Commons License
This work is licensed under a Creative Commons License.